Clinical Trials List
Protocol NumberCYBLR1601
NCT Number(ClinicalTrials.gov Identfier)NA
Not yet recruiting
2017-03-01 - 2018-12-31
Phase III
Terminated2
NA
-
Trial Applicant
Chuang Yi Biotech
-
Sponsor
NA
-
Trial scale
-
Update
2026/09/14
Investigators and Locations
Co-Principal Investigator
- 顧明修醫師 無
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
KUO-WEI YEH
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
NA
Objectives
NA
Test Drug
NA
Active Ingredient
Lactobacillus rhamnosus
Dosage Form
Dosage
300
Endpoints
NA
Inclution Criteria
NA
Exclusion Criteria
NA
The Estimated Number of Participants
-
Taiwan
72 participants
-
Global
72 participants
